文献速递腹部技术与安全PETCT

结直肠癌肝转移中KRAS突变与双时间点18F-FDG PET/CT显像的关系

Relationship between KRAS mutations and dual time point 18F-FDG PET/CT imaging in colorectal liver metastases.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

回顾性纳入49例结直肠癌患者的87个肝转移灶,分析双时间点18F-FDG PET/CT代谢参数与KRAS突变状态的关系。KRAS突变型转移灶的早期和延迟SUVmax、ΔSUVmax及RI均显著高于野生型。多因素分析显示早期和延迟SUVmax、ΔSUVmax及RI是预测KRAS突变的独立因素。

要点

  • KRAS突变型结直肠癌肝转移灶的早期和延迟SUVmax均显著高于野生型。
  • KRAS突变型转移灶的ΔSUVmax和RI也显著高于野生型。
  • 早期和延迟SUVmax、ΔSUVmax及RI是预测KRAS突变的独立因素。

核心结论

  • 早期和延迟扫描的SUVmax、ΔSUVmax及RI可能是预测结直肠癌肝转移患者KRAS突变的4个独立因素。

研究设计与样本

  • 回顾性研究纳入49例结直肠癌患者共87个肝转移灶,所有患者均行KRAS基因突变检测;在早期和延迟显像上测量每个肝转移灶的SUVmax,并计算ΔSUVmax和RI;采用单因素和多因素分析确定PET/CT参数与KRAS突变状态的关系。

诊断标准与关键数值

  • KRAS突变型肝转移灶早期SUVmax为10.7 ± 6.0,野生型为7.8 ± 3.3(P = 0.002);KRAS突变型延迟SUVmax为15.5 ± 10.1,野生型为10.0 ± 4.2(P < 0.001);KRAS突变型ΔSUVmax为4.8 ± 4.7,野生型为2.2 ± 2.0(P < 0.001);KRAS突变型RI(%)为45.3 ± 28.2,野生型为29.6 ± 24.7(P = 0.003)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the association between metabolic parameters of dual time point 18F-FDG PET/CT imaging and Kirsten rat sarcoma (KRAS) mutation status in colorectal liver metastases (CRLM).

METHODS: Forty-nine colorectal cancer patients with 87 liver metastatic lesions were included in this retrospective study. KRAS gene mutation tests were also performed for all the patients. The maximum standardized uptake value (SUVmax) was measured for each hepatic metastatic lesion on both early and delayed scans, and the change of SUVmax (ΔSUVmax) and retention index (RI) were calculated. Uni-variate and multi-variate analyses were employed to determine the relationship between any PET/CT parameters and KRAS mutation status.

RESULTS: Thirty-seven (42.5%) liver metastatic lesions harboring KRAS mutations were identified. The SUVmax of CRLM with KRAS mutation both on early and delayed scans was significantly higher than those with wild-type KRAS (10.7 ± 6.0 vs. 7.8 ± 3.3, P = 0.002; 15.5 ± 10.1 vs. 10.0 ± 4.2, P < 0.001, respectively). Compared with wild-type KRAS CRLM, ΔSUVmax and RI (%) of CRLM with KRAS mutation were also significantly higher than those with wild-type KRAS (4.8 ± 4.7 vs. 2.2 ± 2.0, P < 0.001; 45.3 ± 28.2 vs. 29.6 ± 24.7, P = 0.003, respectively). Multi-variate analyses showed that the SUVmax on both early and delayed scans, ΔSUVmax, and RI (%) were the 4 independent factors to predict CRLM patients harboring KRAS mutations.

CONCLUSION: The SUVmax on both early and delayed scans, ΔSUVmax, and RI (%) may be the 4 independent factors to predict CRLM patients harboring KRAS mutations.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Mao W, Zhou J, Zhang H, et al. Relationship between KRAS mutations and dual time point 18F-FDG PET/CT imaging in colorectal liver metastases. Abdom Radiol (NY). 2019. PMID: 30143816. doi:10.1007/s00261-018-1740-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。